Gilead Sciences insider trading
Health Care · Heavy sellingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 0 Gilead Sciences insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $87.6M. 78 of 79 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 84 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 12,000 | $147.72 | $1.8M | -2.1% | — |
| Oct 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 3,000 | $148.63 | $446K | -2.7% | — |
| Sep 16SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $145.29 | $436K | -0.5% | — |
| Sep 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 1,600 | $143.69 | $230K | +0.7% | — |
| Sep 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 800 | $144.46 | $116K | +0.1% | — |
| Sep 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 600 | $145.29 | $87K | -0.5% | — |
| Sep 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 7,992 | $148.36 | $1.2M | -2.5% | — |
| Sep 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 5,408 | $149.38 | $808K | -3.2% | — |
| Sep 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 1,600 | $147.51 | $236K | -2.0% | — |
| Aug 27SEC | Anthony WeltersDirector | Sell Plan | 6,880 | $148.82 | $1.0M | -2.8% | — |
| Aug 27SEC | Anthony WeltersDirector | Sell Plan | 4,600 | $148.82 | $685K | -2.8% | — |
| Aug 27SEC | Anthony WeltersDirector | Sell Plan | 3,402 | $148.24 | $504K | -2.4% | — |
| Aug 27SEC | Anthony WeltersDirector | Sell Plan | 3,118 | $148.31 | $462K | -2.5% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 1,816 | $144.92 | $263K | -0.2% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 1,658 | $145.73 | $242K | -0.8% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 1,165 | $143.75 | $167K | +0.6% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 335 | $146.26 | $49K | -1.1% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 26 | $146.36 | $4K | -1.2% | — |
| Aug 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 16,530 | $137.37 | $2.3M | +5.3% | — |
| Aug 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 11,470 | $138.04 | $1.6M | +4.8% | — |
| Aug 18SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $138.36 | $415K | +4.5% | — |
| Aug 4SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 7,700 | $130.80 | $1.0M | +10.6% | — |
| Aug 4SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 6,700 | $129.66 | $869K | +11.5% | — |
| Aug 4SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 600 | $131.34 | $79K | +10.1% | — |
| Jul 16SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $129.93 | $390K | +11.3% | — |
| Jul 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 3,000 | $129.92 | $390K | +11.3% | — |
| Jul 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 11,900 | $126.09 | $1.5M | +14.7% | — |
| Jul 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 3,100 | $127.08 | $394K | +13.8% | — |
| Jun 16SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $125.40 | $376K | +15.3% | — |
| Jun 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 1,480 | $123.42 | $183K | +17.2% | — |
| Jun 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 1,070 | $124.00 | $133K | +16.6% | — |
| Jun 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 450 | $125.40 | $56K | +15.3% | — |
| Jun 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 10,900 | $131.10 | $1.4M | +10.3% | — |
| Jun 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 3,062 | $132.22 | $405K | +9.4% | — |
| Jun 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 1,038 | $132.97 | $138K | +8.8% | — |
| May 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 11,177 | $131.19 | $1.5M | +10.2% | — |
| May 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 8,374 | $132.23 | $1.1M | +9.4% | — |
| May 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 7,749 | $130.29 | $1.0M | +11.0% | — |
| May 18SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $132.27 | $397K | +9.3% | — |
| May 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 700 | $132.75 | $93K | +8.9% | — |
| Apr 29SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 6,950 | $128.79 | $895K | +12.3% | — |
| Apr 29SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 3,050 | $130.01 | $397K | +11.2% | — |
| Apr 16SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $140.96 | $423K | +2.6% | — |
| Apr 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 3,000 | $140.96 | $423K | +2.6% | — |
| Mar 30SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 10,000 | $136.82 | $1.4M | +5.7% | — |
| Mar 17SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $144.23 | $433K | +0.3% | — |
| Mar 17SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 3,000 | $144.23 | $433K | +0.3% | — |
| Mar 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 6,419 | $145.18 | $932K | -0.4% | — |
| Mar 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 3,481 | $144.04 | $501K | +0.4% | — |
| Mar 2SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 100 | $145.71 | $15K | -0.7% | — |
| Feb 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 18,405 | $154.18 | $2.8M | -6.2% | — |
| Feb 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 9,395 | $154.91 | $1.5M | -6.6% | — |
| Feb 18SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $154.43 | $463K | -6.3% | — |
| Feb 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 200 | $155.62 | $31K | -7.1% | — |
| Feb 6SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 115,640 | $150.00 | $17.3M | -3.6% | — |
| Jan 29SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 5,032 | $139.54 | $702K | +3.6% | — |
| Jan 29SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 4,968 | $140.24 | $697K | +3.1% | — |
| Jan 26SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 115,640 | $135.00 | $15.6M | +7.1% | — |
| Jan 21SEC | Jeffrey BluestoneDirector | Sell Plan | 5,000 | $123.50 | $618K | +17.1% | — |
| Jan 16SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $124.31 | $373K | +16.3% | — |
| Jan 16SEC | Johanna MercierChief Commercial Officer | Sell Plan | 3,000 | $124.31 | $373K | +16.3% | — |
| Dec 30SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 10,000 | $124.83 | $1.2M | +15.9% | — |
| Dec 16SEC | Andrew D DickinsonCFO | Sell Plan | 3,000 | $122.00 | $366K | +18.5% | — |
| Dec 16SEC | Johanna MercierChief Commercial Officer | Sell Plan | 3,000 | $122.00 | $366K | +18.5% | — |
| Dec 1SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 6,788 | $126.84 | $861K | +14.0% | — |
| Dec 1SEC | Jeffrey BluestoneDirector | Sell | 5,000 | $125.08 | $625K | +15.6% | — |
| Dec 1SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 3,212 | $125.91 | $404K | +14.9% | — |
| Dec 1SEC | Kelly A. KramerDirector | Sell Plan | 2,806 | $127.11 | $357K | +13.8% | — |
| Dec 1SEC | Kelly A. KramerDirector | Sell Plan | 2,805 | $127.10 | $357K | +13.8% | — |
| Nov 18SEC | Johanna MercierChief Commercial Officer | Sell Plan | 25,524 | $125.83 | $3.2M | +14.9% | — |
| Nov 18SEC | Andrew D DickinsonCFO | Sell Plan | 2,500 | $125.23 | $313K | +15.5% | — |
| Nov 18SEC | Johanna MercierChief Commercial Officer | Sell Plan | 2,476 | $126.26 | $313K | +14.6% | — |
| Nov 13SEC | Deborah H TelmanEvp, Corporate Affairs & Gc | Sell Plan | 35,965 | $122.30 | $4.4M | +18.3% | — |
| Nov 13SEC | Deborah H TelmanEvp, Corporate Affairs & Gc | Sell Plan | 17,181 | $124.00 | $2.1M | +16.6% | — |
| Nov 13SEC | Deborah H TelmanEvp, Corporate Affairs & Gc | Sell Plan | 500 | $122.90 | $61K | +17.7% | — |
| Oct 29SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 7,978 | $119.54 | $954K | +21.0% | — |
| Oct 29SEC | Daniel Patrick O'dayCEO, Chair | Sell Plan | 2,022 | $118.82 | $240K | +21.7% | — |
| Oct 16SEC | Johanna MercierChief Commercial Officer | Sell Plan | 3,000 | $118.08 | $354K | +22.5% | — |
| Oct 16SEC | Andrew D DickinsonCFO | Sell Plan | 2,500 | $118.08 | $295K | +22.5% | — |
Insiders at Gilead Sciences
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Daniel Patrick O'dayCEO, Chair | — | $52.4M | Oct 2, 2026 | — |
| Johanna MercierChief Comm & Corp Aff Officer | — | $18.5M | Sep 16, 2026 | — |
| Deborah H TelmanEvp, Corporate Affairs & Gc | — | $6.6M | Nov 13, 2025 | — |
| Andrew D DickinsonCFO | — | $4.7M | Sep 16, 2026 | — |
| Anthony WeltersDirector | — | $2.7M | Aug 27, 2026 | — |
| Jeffrey BluestoneDirector | — | $2.0M | Aug 21, 2026 | — |
| Kelly A. KramerDirector | — | $713K | Dec 1, 2025 | — |
| Erin BurkhartSvp, Controllership | — | — | Sep 23, 2026 | — |
| Wettan Keeley M CainEvp Gen Counsel, Legal & Comp | — | — | Sep 11, 2026 | — |
| Dietmar BergerChief Medical Officer | — | — | Sep 11, 2026 | — |
| Harish ManwaniDirector | — | — | May 4, 2026 | — |
| Jacqueline K BartonDirector | — | — | May 4, 2026 | — |
| Ted W LoveDirector | — | — | May 4, 2026 | — |
| Javier RodriguezDirector | — | — | May 4, 2026 | — |
| Sandra HorningDirector | — | — | May 4, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about GILD insiders
Are Gilead Sciences insiders buying GILD stock?
In the past 12 months, 0 insiders reported open-market purchases of GILD worth $0.
Are Gilead Sciences insiders selling GILD stock?
7 insiders reported sales worth $87.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.